English  |  正體中文  |  简体中文  |  2826208  
???header.visitor??? :  31893388    ???header.onlineuser??? :  1808
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"tsuji a"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-5 of 5  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-01-28T01:06:31Z Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN - A randomized, phase III study Satoh T.;Doi T.;Ohtsu A.;Tsuji A.;Omuro Y.;Mukaiyama A.;Kobayashi M.;Miwa H.;Xu R.-H.;Sun G.-P.;Xu J.-M.;Wang J.-W.;Li J.;Qin S.-K.;Feng J.-F.;Chung H.C.;Bang Y.-J.;Chung I.-J.;Kun-Huei Yeh; Satoh T.; Doi T.; Ohtsu A.; Tsuji A.; Omuro Y.; Mukaiyama A.; Kobayashi M.; Miwa H.; Xu R.-H.; Sun G.-P.; Xu J.-M.; Wang J.-W.; Li J.; Qin S.-K.; Feng J.-F.; Chung H.C.; Bang Y.-J.; Chung I.-J.; KUN-HUEI YEH
臺大學術典藏 2021-01-28T01:06:19Z Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: A randomized Phase III study Li J.;Xu R.;Qin S.;Liu T.;Pan H.;Xu J.;Bi F.;Lim R.;Zhang S.;Ba Y.;Bai Y.;Fan N.;Tsuji A.;Kun-Huei Yeh;Ma B.;Wei V.;Shi D.;Magherini E.;Shen L.; Li J.; Xu R.; Qin S.; Liu T.; Pan H.; Xu J.; Bi F.; Lim R.; Zhang S.; Ba Y.; Bai Y.; Fan N.; Tsuji A.; KUN-HUEI YEH; Ma B.; Wei V.; Shi D.; Magherini E.; Shen L.
國立成功大學 2019 A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy re Kato, Kato K.;Satoh, T.;Muro, K.;Yoshikawa, T.;Tamura, Tamura T.;Hamamoto, Y.;Chin, K.;Minashi, K.;Tsuda, M.;Yamaguchi, K.;Machida, N.;Esaki, T.;Goto, M.;Komatsu, Y.;Nakajima, T.E.;Sugimoto, N.;Yoshida, K.;Oki, E.;Nishina, T.;Tsuji, A.;Fujii, H.;Kunieda, Kunieda K.;Saitoh, Saitoh S.;Omuro, Y.;Azuma, M.;Iwamoto, Y.;Taku, K.;Fushida, S.;Chen, L.-T.;Kang, Y.-K.;Boku, N.
國立成功大學 2019 Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design Moehler, Moehler M.;Ryu, M.-H.;Dvorkin, M.;Lee, K.-W.;Coşkun, H.Ş.;Wong, R.;Chung, H.C.;Poltoratsky, A.;Tsuji, A.;Yen, C.J.;Muntean, A.S.;Le, Sourd S.;Vaccaro, G.M.;Overton, L.;Boku, N.;Wainberg, Z.A.;Patel, M.;Sharma, M.;Xiong, H.;Conti, I.;Taieb, J.;Bang, Y.-J.
國家衛生研究院 2018-12-01 A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens Kato, K;Satoh, T;Muro, K;Yoshikawa, T;Tamura, T;Hamamoto, Y;Chin, K;Minashi, K;Tsuda, M;Yamaguchi, K;Machida, N;Esaki, T;Goto, M;Komatsu, Y;Nakajima, TE;Sugimoto, N;Yoshida, K;Oki, E;Nishina, T;Tsuji, A;Fujii, H;Kunieda, K;Saitoh, S;Omuro, Y;Azuma, M;Iwamoto, Y;Taku, K;Fushida, S;Chen, LT;Kang, YK;Boku, N

Showing items 1-5 of 5  (1 Page(s) Totally)
1 
View [10|25|50] records per page